Is LH or WST cheaper?

On trailing earnings, LH is cheaper: LH trades at a 24.05 P/E and WST at 46.84.

Which has grown faster, LH or WST?

Over the past five years, WST grew revenue faster — LH at a -1.58% CAGR versus WST at 6.72%.

Does LH or WST pay a bigger dividend?

LH yields 1.06% and WST yields 0.25% based on trailing dividends and the latest price.

Is LH or WST more profitable?

WST runs the higher net margin — LH at 6.66% versus WST at 16.85%.

Which has been the better investment, LH or WST?

Over the past 10-year, WST delivered the higher annualized total return — LH at 9.88% versus WST at 17.45%. Past performance doesn't predict future results.

Labcorp Holdings Inc. (LH) vs West Pharmaceutical Services, Inc. (WST)

LH leads on 9 of 17 compared metrics.

A side-by-side comparison of Labcorp Holdings Inc. and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 27, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Labcorp Holdings Inc.

$22.26B

$271.47Healthcare

WST

West Pharmaceutical Services, Inc.

$24.79B

$350.85Healthcare

Total return — LH vs WST

growth of $100 · last 30y

LH +1505.4%WST +5121.0%WST compounded faster

LH WST

LH vs WST: by the numbers

•WST is the larger company ($24.79B vs $22.26B market cap).
•LH trades at the lower earnings multiple (24.05 vs 46.84 P/E).
•WST converts more revenue to profit (16.85% vs 6.66% net margin).
•WST grew revenue faster over the past five years (6.72% vs -1.58% CAGR).
•LH pays the higher dividend yield (1.06% vs 0.25%).

Which is better, LH or WST?

Metric tally: LH 9 · WST 8

It depends on what you're optimizing for:

ValueLH(lower P/E)

GrowthWST(faster 5Y revenue CAGR)

IncomeLH(higher dividend yield)

QualityWST(higher ROIC)

Metrics side by side

Valuation

Metric	LH	WST
P/E ratio	24.05●	46.84
Forward P/E	13.93●	36.63
P/S ratio	1.59●	7.89
P/B ratio	2.58●	8.49
PEG ratio	1.28●	33.99
EV / EBITDA	12.80●	29.94
FCF yield	6.15%●	1.80%

Profitability

Metric	LH	WST
Gross margin	27.79%	36.24%●
Operating margin	11.03%	20.67%●
Net margin	6.66%	16.85%●
ROE	10.79%	18.15%●
ROIC	7.39%	13.62%●

Dividends

Metric	LH	WST
Dividend yield	1.06%●	0.25%
Payout ratio	27.32%	12.88%

Growth (annualized)

Metric	LH	WST
Revenue CAGR (5Y)	-1.58%	6.72%●
EPS CAGR (5Y)	-8.00%	7.85%●
FCF CAGR (5Y)	-12.63%	8.32%●
Total return CAGR (5Y)	4.47%●	-0.26%

Frequently asked

Which is better, LH or WST?: It depends on your goal. value: LH (lower P/E); growth: WST (faster 5Y revenue CAGR); income: LH (higher dividend yield); quality: WST (higher ROIC). Across all compared metrics, LH leads 9 to 8.
Is LH or WST cheaper?: On trailing earnings, LH is cheaper: LH trades at a 24.05 P/E and WST at 46.84.
Which has grown faster, LH or WST?: Over the past five years, WST grew revenue faster — LH at a -1.58% CAGR versus WST at 6.72%.
Does LH or WST pay a bigger dividend?: LH yields 1.06% and WST yields 0.25% based on trailing dividends and the latest price.
Is LH or WST more profitable?: WST runs the higher net margin — LH at 6.66% versus WST at 16.85%.
Which has been the better investment, LH or WST?: Over the past 10-year, WST delivered the higher annualized total return — LH at 9.88% versus WST at 17.45%. Past performance doesn't predict future results.

Go deeper

Full LH analysis Full WST analysis Interactive comparison tool

Dig into the metrics

Labcorp P/E ratio West Pharmaceutical Services P/E ratio Labcorp dividend yield West Pharmaceutical Services dividend yield Labcorp ROE West Pharmaceutical Services ROE Labcorp operating margin West Pharmaceutical Services operating margin Labcorp revenue growth West Pharmaceutical Services revenue growth Labcorp free cash flow West Pharmaceutical Services free cash flow

Labcorp & West Pharmaceutical Services appear in these rankings

Dividend Aristocrats Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 27, 2026.